PharmaShots | Incisive News in 3 Shots

Subscribe Now

LRRK2 Program

Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson's Disease Worth ~$2.125B

Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson's Disease Worth ~$2.125B

August 7, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us